17th Global Conf. on Pharmaceutical Sciences, Drugs & Healthcare Innovation
About this Event
The 17th Global Conf. on Pharmaceutical Sciences, Drugs & Healthcare Innovation is an in-person event for people interested in pharmaceutical sciences, drugs and healthcare innovation.
INVITATION LETTER is provided upon registration for the event
Contact: [email protected]
About the conference
The 17th Global Conference on Pharmaceutical Sciences, Drug Development, and Healthcare Innovation (GCPPS) 2027 aims to bring together researchers, pharmacists, healthcare professionals, industry representatives, and academic leaders to exchange knowledge across the development and use of medicines.
The conference will explore the connections between pharmaceutical research, drug development, manufacturing quality, medicine safety, and patient care. It will also provide a forum to discuss how biotechnology, digital tools, and interdisciplinary collaboration can support healthcare innovation.
The proposed programme combines keynote presentations, panel discussions, research presentations, interactive workshops, and professional networking. Participants will have opportunities to share experience, discuss challenges, and consider practical approaches relevant to research, industry, education, and healthcare delivery.
The conference welcomes professionals working across the medicine lifecycle—from early discovery and formulation to clinical research, production, distribution, and use in patient care.
Conference objectives
- Encourage knowledge exchange across pharmaceutical science and healthcare.
- Explore approaches to drug discovery, development, and delivery.
- Discuss medicine safety, quality, and responsible research practices.
- Examine the role of biotechnology, AI, and digital health.
- Connect research and industry perspectives with patient and community needs.
- Encourage professional relationships across institutions, disciplines, and countries.
- Support discussion on equitable access to quality medicines.
Key topics and discussion areas
Pharmaceutical research and drug discovery
- Identifying and evaluating potential therapeutic compounds
- Translational research and interdisciplinary collaboration
- Preclinical research methods
- Natural products and medicinal chemistry
- Research reproducibility and scientific integrity
Drug development and formulation
- Formulation design and pharmaceutical analysis
- Drug delivery systems
- Stability and product development
- Biopharmaceutics and pharmacokinetics
- Challenges in moving research towards clinical application
Clinical research and evidence generation
- Clinical trial design and research ethics
- Participant engagement and informed consent
- Clinical data quality and interpretation
- Representation and inclusion in clinical research
- Communicating research findings responsibly
Biotechnology and emerging therapies
- Biopharmaceutical research and development
- Vaccine research
- Precision medicine
- Cell and gene therapy research
- Collaboration between biotechnology companies and academic institutions
Manufacturing and pharmaceutical quality
- Manufacturing processes and quality systems
- Quality assurance and quality control
- Analytical testing and product consistency
- Supply chain integrity and storage
- Sustainable pharmaceutical production
Medicine safety and Ph*rm*cy practice
- Pharmacovigilance and adverse event reporting
- Medic*tion safety and appropriate medicine use
- Patient counselling and health literacy
- Collaboration between pharmacists and other healthcare professionals
- Antimicrobial stewardship
Digital health, AI, and healthcare innovation
- AI applications in pharmaceutical research
- Digital tools for clinical research and patient support
- Health data quality, privacy, and responsible use
- Digital Ph*rm*cy services
- Assessing the value and limitations of healthcare technologies
Access, policy, and pharmaceutical business
- Access to essential medicines
- Pharmaceutical supply and distribution
- Health systems and medicine affordability
- Research commercialisation and entrepreneurship
- Industry partnerships and responsible innovation
Who should attend?
- Pharmaceutical scientists and researchers
- Pharmacists and Ph*rm*cy managers
- Drug discovery and formulation specialists
- Clinical researchers and trial coordinators
- Biotechnology professionals
- Pharmaceutical manufacturing and quality professionals
- Pharmacovigilance and medicine safety specialists
- Physicians, nurses, and allied healthcare professionals
- Public health and health policy practitioners
- Digital health developers and entrepreneurs
- University lecturers, postgraduate researchers, and students
- Pharmaceutical business and supply chain professionals
Why attend?
Participants can:
- Explore research and practical challenges across the pharmaceutical sector.
- Learn from experiences shared across disciplines and professional settings.
- Discuss approaches to medicine quality, safety, and patient care.
- Exchange ideas about emerging technologies and healthcare innovation.
- Present accepted research or professional work.
- Build connections for potential future collaboration.
Two-day agenda
Day 1 — Pharmaceutical Research and Drug Development
TimeSession8:30–9:00 AMRegistration and welcome networking9:00–9:20 AMOpening remarks and conference introduction9:20–10:10 AMOpening keynote: Connecting Pharmaceutical Discovery with Patient Needs10:10–10:30 AMNetworking break10:30–11:30 AMPanel: Challenges and Opportunities in Drug Discovery and Development11:30 AM–12:30 PMResearch presentations: Formulation, Drug Delivery, and Pharmaceutical Analysis12:30–1:30 PMLunch break1:30–2:30 PMSession: Biotechnology and Emerging Therapeutic Approaches2:30–3:15 PMWorkshop: Research Design, Reproducibility, and Scientific Communication3:15–3:30 PMNetworking break3:30–4:30 PMPanel: Clinical Research, Ethics, and Evidence Generation4:30–5:00 PMQuestions, discussion, and day-one reflections
Day 2 — Medicine Safety, Quality, and Healthcare Innovation
TimeSession8:30–9:00 AMArrival and professional networking9:00–9:15 AMWelcome and recap9:15–10:15 AMKeynote: Pharmaceutical Innovation and the Future of Patient Care10:15–10:30 AMNetworking break10:30–11:30 AMPanel: Manufacturing Quality and Pharmaceutical Supply Chains11:30 AM–12:30 PMSession: Pharmacovigilance, Medic*tion Safety, and Ph*rm*cy Practice12:30–1:30 PMLunch break1:30–2:30 PMPanel: AI, Digital Ph*rm*cy, and Responsible Health Technology2:30–3:15 PMResearch and case-study presentations: Access to Medicines and Healthcare Delivery3:15–3:30 PMNetworking break3:30–4:15 PMRoundtable: Collaboration Across Research, Industry, and Healthcare4:15–4:45 PMParticipant reflections and practical next steps4:45–5:00 PMClosing remarks
Your ticket includes: Confirm session access, workshops, materials, refreshments, meals, and attendance certificate.
Travel, accommodation, insurance, and personal expenses are excluded unless expressly included. Scheduled breaks do not imply that catering is provided.
Call for abstracts and presentations
YOU can email us with proposal for your work if you wish to present
Researchers, practitioners, and students are invited to submit proposals related to the conference themes. Submissions may include original research, literature reviews, case studies, or professional practice projects.
Proposals will be assessed for relevance, clarity, and scientific or professional contribution.
International participants and invitation letters
International delegates are welcome.
invitation letters are offered, registered participants may request a letter through [[email protected]], quoting their registration reference and providing the information required to prepare an accurate letter.
An invitation letter confirms registration and the participant’s agreed conference role. Registration and invitation letters do not guarantee a visa or entry into Canada. Participants are responsible for checking official travel requirements and arranging their travel, accommodation, and insurance.
Refunds,
No Refund
Participation terms and disclaimer
- The conference provides a forum for education and professional exchange. Presentations do not replace individual clinical advice.
- Discussion of a medicine, technology, or service does not imply endorsement by the organizer.
- Speakers and presenters should disclose relevant commercial interests.
- Presenters are responsible for obtaining permission to share research, images, and other protected material. Patient information must be appropriately anonymised.
- Programme details may change. Material updates will be communicated through official event channels.
- Participants must behave respectfully and follow venue rules.
- Any attendance certificate confirms participation only. Continuing education credits or professional accreditation will be advertised only if confirmed.
- Photography and recording arrangements will be communicated in advance, including how attendees can raise privacy concerns.
Frequently asked questions
Is this conference only for pharmaceutical researchers?
No. It also welcomes pharmacists, healthcare professionals, educators, students, biotechnology specialists, and industry professionals.
Can I attend without presenting?
Yes. You can register as a delegate without submitting an abstract.
Will I receive a certificate?
Yes but certificate of attendance
Are meals and accommodation included?
Only items expressly listed in the ticket description are included. if epty then none.
Where is it happening?
GBP 0.00 to GBP 145.69














![Real Estate Investor Accelerator 3-Day Bootcamp (Etobicoke, ON) [112026]](https://cdn-ip.allevents.in/s/rs:fill:500:250/g:sm/sh:100/aHR0cHM6Ly9jZG4tYXouYWxsZXZlbnRzLmluL2V2ZW50czUvYmFubmVycy9kNDFlY2E2Y2NmMmJhN2ZhYzRhNzI2MDc1MWRjODA3ZTNhNmU3MTI0N2M4ZDUzZjAwNGRhNWJkMDExYzM0MzMyLXJpbWctdzEyMDAtaDYwMC1kYzA4MDgwOC1nbWlyLmpwZz92PTE3ODk0OTI4MDQ.avif)


